References
Lam MT, Coppola S, Krumbach O, Prencipe G, Insalaco A, Cifaldi C, et al. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function. J Exp Med. 2019.
Gernez Y, de Jesus AA, Alsaleem H, Macaubas C, Roy A, Lovell D, et al. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1beta inhibition. J Allergy Clin Immunol. 2019;144(4):1122–5.
Ding Y, Zhou L, Xia Y, Wang W, Wang Y, Li L, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142(3):970–3.
Yang L, Wang L, Geiger H, Cancelas JA, Mo J, Zheng Y. Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow. Proc Natl Acad Sci U S A. 2007;104(12):5091–6.
Yang L, Wang L, Kalfa TA, Cancelas JA, Shang X, Pushkaran S, et al. Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis. Blood. 2007;110(12):3853–61.
Pleines I, Eckly A, Elvers M, Hagedorn I, Eliautou S, Bender M, et al. Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in platelets. Blood. 2010;115(16):3364–73.
Pleines I, Dutting S, Cherpokova D, Eckly A, Meyer I, Morowski M, et al. Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42. Blood. 2013;122(18):3178–87.
Takenouchi T, Kosaki R, Niizuma T, Hata K, Kosaki K. Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: yet another locus for thrombocytopenia and developmental delay. Am J Med Genet A. 2015;167A(11):2822–5.
Bucciol G, Pillay B, Casas-Martin J, Delafontaine S, Proesmans M, Lorent N, et al. Systemic inflammation and myelofibrosis in a patient with Takenouchi-Kosaki syndrome due to CDC42 Tyr64Cys mutation. J Clin Immunol. 2020.
Guo F, Velu CS, Grimes HL, Zheng Y. Rho GTPase Cdc42 is essential for B-lymphocyte development and activation. Blood. 2009;114(14):2909–16.
Burbage M, Keppler SJ, Gasparrini F, Martinez-Martin N, Gaya M, Feest C, et al. Cdc42 is a key regulator of B cell differentiation and is required for antiviral humoral immunity. J Exp Med. 2015;212(1):53–72.
Gerasimcik N, Dahlberg CI, Baptista MA, Massaad MJ, Geha RS, Westerberg LS, et al. The Rho GTPase Cdc42 is essential for the activation and function of mature B cells. J Immunol. 2015;194(10):4750–8.
Biggs CM, Keles S, Chatila TA. DOCK8 deficiency: insights into pathophysiology, clinical features and management. Clin Immunol. 2017;181:75–82.
Tangye SG, Pillay B, Randall KL, Avery DT, Phan TG, Gray P, et al. Dedicator of cytokinesis 8-deficient CD4(+) T cells are biased to a TH2 effector fate at the expense of TH1 and TH17 cells. J Allergy Clin Immunol. 2017;139(3):933–49.
Gowthaman U, Chen JS, Zhang B, Flynn WF, Lu Y, Song W, et al. Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science. 2019;365(6456).
Acknowledgments
We thank all the patients, their families, and the healthy controls for the participation. We thank Huan Zhang (Department of Pathology, Shenzhen Children’s hospital, China) for providing pictures of BM smear from the patient and a control diagnosed with ITP. We especially thank Lixin Zheng (Molecular Development of the Immune System Section, Laboratory of Immune System Biology, and Clinical Genomics Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases) and Sicai Zhang for the correction of grammatical errors.
Funding
This work was supported by the Sanming Project of Medicine in Shenzhen (no. SZSM201812002) and Science and Technology Planning Project of Shenzhen Municipality (JCY20170303155201082).
Author information
Authors and Affiliations
Contributions
Tingyan He and Yanyan Huang contributed equally to this work. Tingyan He and Yanyan Huang performed the main experiments, analyzed the data, and drafted the manuscript. Jiayun Ling collected clinical data from the patient. Jun Yang reviewed the manuscript. All authors reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
All participated family members were enrolled with the approval of the ethics committee of Shenzhen Children’s hospital and provided written consent.
Conflict of Interest
The authors declare that there is no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 35 kb)
Rights and permissions
About this article
Cite this article
He, T., Huang, Y., Ling, J. et al. A New Patient with NOCARH Syndrome Due to CDC42 Defect. J Clin Immunol 40, 571–575 (2020). https://doi.org/10.1007/s10875-020-00786-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-020-00786-7